Sigma Planning Corp Dexcom Inc Transaction History

Sigma Planning Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$114.22 - $140.1 $179,211 - $219,816	1,569 New	1,569 $217,000
Q2 2022 Aug 11, 2022	SELL	$67.99 - $132.89 $26,584 - $51,959	-391 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$94.08 - $130.2 $1,128 - $1,562	12 Added 3.17%	391 $200,000
Q4 2021 Feb 02, 2022	SELL	$129.87 - $162.82 $12,987 - $16,282	-100 Reduced 20.88%	379 $204,000
Q2 2021 Aug 13, 2021	SELL	$80.99 - $107.93 $11,095 - $14,786	-137 Reduced 22.24%	479 $205,000
Q1 2021 May 06, 2021	BUY	$84.79 - $104.74 $3,815 - $4,713	45 Added 7.88%	616 $221,000
Q4 2020 Feb 09, 2021	SELL	$78.0 - $104.5 $11,544 - $15,466	-148 Reduced 20.58%	571 $211,000
Q3 2020 Nov 03, 2020	SELL	$95.51 - $112.95 $6,112 - $7,228	-64 Reduced 8.17%	719 $296,000
Q2 2020 Jul 31, 2020	BUY	$62.68 - $105.34 $49,078 - $82,481	783 New	783 $318,000
Q4 2019 Feb 03, 2020	SELL	$36.62 - $57.29 $53,318 - $83,414	-1,456 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$35.53 - $43.8 $51,731 - $63,772	1,456 New	1,456 $217,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.